Summary.-Local injection (i.e. injection at the site of tumour inoculation) of strains of C. Parvum which have a significant anti-tumour effect when given systemically (i.e. intravenously or, in the case of subcutaneous tumour transplant, intraperitoneally) strongly inhibits the growth of isogeneic transplants of a fibrosarcoma in intact CBA mice but has little or no effect on subcutaneous transplants of the same tumour in T-cell deprived mice. The anti-tumour effect of local injection of C. parvum, unlike that of systemic injection in this particular tumour system, thus appears to be T-cell dependent.
PRELIMINARY observations of our own with a mouse fibrosarcoma, and experiments with other mouse tumours recently reported by Likhite and Halpern (1974) and Scott (1974) , have shown that intratumour injection of C. parvum may strongly inhibit tumour growth and under some conditions cause complete regression.
The present experiments were designed to investigate this phenomenon further, using both subcutaneous and intraperitoneal tumour transplants. To exclude purely mechanical effects we have compared the degree of tumour inhibition resulting from local injection of 3 anaerobic coryneforms which differ markedly in their effect on tumour growth when given systemically, and of an aerobic organism, C. diphtheriae.
We have used as tumour hosts both intact and T-cell deprived mice, because in our own experience (Wooodruff and Dunbar, 1972; Woodruff, Dunbar and Ghaffar, 1973) , the anti-tumour effect of systemic injections of active strains of C. parvum in respect of cholanthrene induced sarcomata is maintained in T-cell deficient mice, whereas Scott (1974) has reported that the growth of a mastocytoma, is inhibited by intratumour injection of C. parvum in intact mice but not in T-cell deprived mice.
MATERIALS AND METHODS
Mice.-The recipient mice were either intact adult CBA females (20-22 g) or T-cell deprived CBA females prepared as described previously (Woodruff et al., 1973) .
Tumour. The tumour was originally induced in a female CBA mouse with methylcholanthrene. It was stored in liquid nitrogen after 1]5 transplant generations and was transplanted once more before being used in the experiments. The properties of this tumour have been summarized in a recent review (Woodruff, 1975) . It was transplanted subcutaneously (right foreleg) or intraperitoneally, or by both these routes, in the form of a cell suspension prepared with pronase in a dosage (unless otherwise stated) of 104 cells.
The mice were inspected and weighed every 2 days. If a subcutaneous tumour was present, its width in 2 directions at rightangles was measured with a caliper and the mean was recorded. Where appropriate, the diameters of subcutaneous tumours were summed, as described previously (Woodruff et al., 1973) , up to the day when some of the tumours in control mice were 18-20 mm in diameter, and the group mean sums were compared by Student's t-test. In many cases, however, the differences between groups were sufficiently clearcut to make this unnecessary. (Woodruff and Dunbar, 1972) ; 10387(2) inhibits tumour growth to some extent when given i.v. or i.p. but is much less effective than CN6134 (McBride et al., 1975) . It is of interest that 3 other distinguishable strains derived from NTC 10387 were studied by O'Neill, Henderson and White (1973) , so it seems likely that the original culture from Colindale contained a mixture of organisms.
A formol killed suspension of C. diphtheriae containing 7 mg dry weight organism per ml (i.e. the same as the suspension of CN6134) was kindly prepared for us by the Wellcome Fouiidation. This material, given i.p. or i.v. in a dosage of 1-4 mg dry weight organisms, has no demonstable anti-tumour effect.
All the organisms were injected in the form of a formalin killed suspension by one of the following routes: (1) intravenously, to a tail vein (i.v.); (2) intraperitoneally (i.p.); (3) subcutaneously to a limb which had not been used for tumour inoculation (s.c.); (4) subcutaneously to a limb which had been used for tumour inoculation at an adjacent site (s.c. adj.): (5) at the site of subcutaneous tumour inoculation or into a palpable subcutaneous tumour (i.t.).
The dose, expressed as the dry weight of organisms, was either 1-4 mg or 0 7 mg. The volume of suspension injected was usually 0-1 ml; occasionally 0-05 ml was used for s.c., s.c. adj. and i.t. injection and 0-2 ml for i.p. injection.
RESULTS
The effect on tumour growth of 3 different organisms injected by various routes after s.c. tumour inoculation is shown in Fig. 1-3 , each of which relates to a separate experiment with 6 mice in each treatment group. It will be seen that C. diphtheriae and C. parvum strain 10387
(1), which are iineffective when given systemically (i.v. or i.p.), were also ineffective ( Fig. 1 ) when injected at the site of tumour inoculation (i.t.). C. parvum strain 10387(2), which has a slight anti-tumour effect when given systemically, had a somewhat greater effect when injected i.t. (Fig. 3) . C. parvum strain CN6134, which is considerably more effective than 10387(2) when given systemically, had an even more marked effect when injected i.t. (Figs. 1,2,3) . In one experiment i.t. injection of this strain (CN6134) 3 days after subcutaneous inoculation of 104 viable tumour cells completely suppressed the development of tumours (Fig. 2) and it was found subsequently that the mice had become resistant to challenge with 105 viable cells. Injection at a site adjacent to tumour inoculation also provided some degree of inhibition, as judged by comparison with tumour growth in untreated control mice (t 1-91, n 10, P<0 05) though it was less effective than i.v. or i.p. injection, whereas subcutaneous injection at a site remote from tumour inoclation was ineffective. In another experiment (Fig. 3) , injection of strain CN6134 into palpable tumours about 4 mm in diameter also appeared to cause significant inhibition, as judged by the difference in mean tumour diameter in treated and control animals 2 weeks later (t=-239, n-10, P<0 05). Figure 8 shows the results of an experiment set up to compare the effect of i.t. injection of C. parvum 3 days after tumour inoculation in intact and T-cell deprived mice. As we have reported previously (Woodruff and Dunbar, 1972; Woodruff et al., 1973) the tumour grows more slowly in untreated T-cell deprived mice than in untreated intact mice, and is inhibited by i.p. injection of C. parvum to much the same extent in both categories of mouse. Injection of C. parvum at the site oftumour inoculation, however, appeared to be ineffective in T-cell deprived mice.
D)ISCUSSION
Our results confirm and extend those of Likhite and Halpern (1974) , and Scott (1974) , and establish beyond doubt that local injection of strains of C. parvum which have a significant anti-tumour effect when given systemically strongly inhibits tumour growth in intact mice whether the tumour (and hence the local injection of C. parvum) is situated subcutaneously or in the peritoneal cavity. Moreover, animals in which tumour growth is completely suppressed following local injection of C. parvum become strongly resistant to a second inoculation of tumour cells.
The effect cannot be attributed to mechanical dispersion of tumour cells or disruption of a growing tumour because organisms which are morphologically similar but fail to inhibit tumour growth when given systemically are also ineffective when given locally.
It seemed at first that the most likely explanation of the anti-tumour effect of local injection of C. parvum was that it promoted the accumulation of macrophages at the site of tumour inoculation. The observation of Scott (1974) , which our own findings appear to confirm, that local injection of C. parvum in T-cell deprived mice is relatively ineffective whereas, as previously reported (Woodruff et al., 1973) , systemic injection is just as effective as in intact mice, would seem to imply that this simple explanation cannot be the whole story and raises again the question Further experiments are planned to investigate this hypothesis, but as a first step it is proposed to find out whether the phenomenon is indeed a general one by conducting similar experiments to those described with other tumours and in congenitally athymic mice.
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